Late gastrointestinal morbidity in patients with stage I-II testicular seminoma treated with radiotherapy

Urologic Oncology
Christopher L HallemeierRichard Choo

Abstract

To define the incidence and risk factors for late gastrointestinal (GI) morbidity in patients with testicular seminoma treated with radiotherapy (RT). A retrospective review was conducted of 251 patients with stage I or II testicular seminoma treated with curative-intent RT at our institution from 1974 to 2009. All patients underwent orchiectomy and postoperative external beam RT to the involved nodal basin or at-risk nodal basin or both. Potential late GI morbidities that were assessed included endoscopically confirmed peptic ulcer disease (PUD), small bowel obstruction (SBO), and biopsy-confirmed malignancy of the GI tract. The probabilities of these GI morbidities were estimated with the Kaplan-Meier method. Univariate analyses were performed to examine for associated predictive factors using the Cox proportional hazards model. Median age at diagnosis was 36 years (range 18-80). Clinical stage was I (n = 199) or II (n = 52). Median abdominopelvic RT dose was 26Gy (interquartile range = 25-30). Median follow-up was 15 years (range = 0.1-38). PUD risk at 10, 20, and 30 years was 4%, 7%, and 9%, respectively. Age at diagnosis (per y, HR = 1.05, 95% CI 1.00-1.09, P = 0.04) and RT dose (per Gy, HR = 1.20, 95% CI 1.09-1.31, P<0.01...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·G E HanksJ Owen
Feb 1, 1989·International Journal of Radiation Oncology, Biology, Physics·S D FossåO Kaalhus
Jun 1, 1986·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C HamiltonM J Peckham
Apr 1, 1995·The British Journal of Radiology·K A VallisG R Kerr
Mar 8, 2000·International Journal of Radiation Oncology, Biology, Physics·C G WillettD K Podolsky
Jul 1, 1955·A.M.A. Archives of Internal Medicine·I B BRICK
Jun 1, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Wojciech MajewskiRafal Tarnawski
Apr 5, 2007·Journal of the National Cancer Institute·Sophie D FossåLois B Travis
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexandra W van den Belt-DuseboutFlora E van Leeuwen
Jan 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Daniel R ZwahlenUwe Schneider
May 1, 1948·Cancer·W G CAHAN, H Q WOODARD
Feb 18, 2009·Alimentary Pharmacology & Therapeutics·J J Y SungH B El-Serag
Mar 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Brian D KavanaghMoyed Miften
Jan 18, 2011·International Journal of Radiation Oncology, Biology, Physics·Charles B SimoneJohn O'Connell
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 5, 2014·Der Urologe. Ausg. A·F ZengerlingM Schrader
Sep 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P GiannatempoA Necchi
May 6, 2016·Clinical Oncology : a Journal of the Royal College of Radiologists·S M GlaserS Beriwal
May 4, 2017·Current Opinion in Oncology·Hampig Raphael Kourie, Jean A Klastersky
Aug 28, 2014·Expert Review of Anticancer Therapy·Roberto IacovelliGiuseppe Procopio
Nov 16, 2021·World Journal of Urology·Julia HeinzelbeckerChristoph Oing

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.